| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.428 | 31.396 | 35.018 | 41.691 | 49.678 | 41.059 | 52.652 | 46.795 | - | 60.219 |
| Total Income - EUR | 35.341 | 32.136 | 36.020 | 42.612 | 49.692 | 41.075 | 52.684 | 46.844 | - | 60.231 |
| Total Expenses - EUR | 33.268 | 30.419 | 34.657 | 44.747 | 54.486 | 44.485 | 48.942 | 58.210 | - | 57.227 |
| Gross Profit/Loss - EUR | 2.073 | 1.717 | 1.363 | -2.135 | -4.794 | -3.410 | 3.742 | -11.366 | - | 3.004 |
| Net Profit/Loss - EUR | 1.013 | 1.074 | 1.003 | -2.561 | -5.307 | -3.783 | 3.210 | -11.829 | - | 2.546 |
| Employees | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | - | 1 |
Check the financial reports for the company - Sprintean Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.690 | 15.530 | 15.267 | 20.441 | 20.045 | 19.665 | 19.229 | 19.288 | - | 19.122 |
| Current Assets | 11.672 | 10.736 | 13.371 | 10.145 | 11.236 | 16.898 | 15.446 | 47.269 | - | 19.058 |
| Inventories | 3.914 | 4.377 | 4.415 | 2.559 | 2.463 | 2.819 | 1.253 | 7.259 | - | 10.073 |
| Receivables | 1.873 | 430 | 2.335 | 4.513 | 3.882 | 4.321 | 13.023 | 33.262 | - | 3.349 |
| Cash | 5.885 | 5.928 | 6.621 | 3.073 | 4.890 | 9.758 | 1.170 | 6.748 | - | 5.636 |
| Shareholders Funds | -1.384 | -296 | 712 | -1.862 | -7.133 | -10.781 | -7.331 | -19.183 | - | 1.830 |
| Social Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Debts | 28.746 | 26.561 | 27.926 | 32.448 | 38.414 | 47.344 | 42.006 | 85.741 | - | 36.351 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Sprintean Pharm Srl